Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > 80%of all stocks are down now!!!!!

<< Previous

Bullboard Posts

Next >>

Post by losermeon Mar 04, 2021 2:47pm

117 Views

Post# 32717198

80%of all stocks are down now!!!!!

We came a long, long, long way from eight months ago. I'm very happy with the way Kly is going at this point. If you don't like it just go and take your chances with another stock that might halt for a few months. Kly won't go there again and from here on , a smooth trading experience and a huge opportunity with NO during this COVID much needed period to save lives. Kly is well known now with its high trading volumes since it was unhalted and that put it ahead of other penny stocks. Just watch and see!!!!

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3